In a previous study, one HER2-binding affibody molecule, ZHER2342, had better tumour uptake and provided higher tumour-to-blood ratios than did HER2-binding scFv antibody fragments in the imaging of HER2-expressing SKOV-3 xenografts22. This evidence concerns the gene ERBB2 and neoplasm.